-
Product Insights
Keystone Grp – Keystone at Mebane Oaks – North Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Keystone Grp - Keystone at Mebane Oaks - North Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Keystone Lifespaces – Keystone Altura Residential Complex – Maharashtra
Equip yourself with the essential tools needed to make informed and profitable decisions with our Keystone Lifespaces - Keystone Altura Residential Complex - Maharashtra report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Glenwood Dev/ Keystone Grp – Keystone At Walkertown Landing Apartments – North Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Glenwood Dev/ Keystone Grp - Keystone At Walkertown Landing Apartments - North Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
NorthPoint Dev – Keystone Trade Center – Pennsylvania
Equip yourself with the essential tools needed to make informed and profitable decisions with our NorthPoint Dev - Keystone Trade Center - Pennsylvania report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Kaneff Corp – Keystone Condominium Development – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kaneff Corp - Keystone Condominium Development - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Atrasentan Hydrochloride in Focal Segmental Glomerulosclerosis (FSGS)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Atrasentan Hydrochloride in Focal Segmental Glomerulosclerosis (FSGS) Drug Details: Atrasentan hydrochloride (ABT-627) is under development...
-
Product Insights
Keystone Realtors – Rustomjee Summit Residential Tower – Maharashtra
Equip yourself with the essential tools needed to make informed and profitable decisions with our Keystone Realtors - Rustomjee Summit Residential Tower - Maharashtra report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
NAI Keystone – Millersville Mixed-Use Development – Pennsylvania
Equip yourself with the essential tools needed to make informed and profitable decisions with our NAI Keystone - Millersville Mixed-Use Development - Pennsylvania report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Keystone – Glen Carbon Senior Living Community – Illinois
Equip yourself with the essential tools needed to make informed and profitable decisions with our Keystone - Glen Carbon Senior Living Community - Illinois report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Shaikan Field, Iraq
Shaikan upstream field is located in Arbil, Iraq. The upstream field is owned by Gulf Keystone Petroleum International Ltd (80%); Kalegran Ltd (20%). It is operated by Gulf Keystone Petroleum International Ltd. The project started its operations in 2010. Shaikan Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Melphalan Hydrochloride in Ocular Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Melphalan Hydrochloride in Ocular Melanoma Drug Details: Melphalan hydrochloride (Hepzato Kit) is a phenylpropanoic acid...
-
Product Insights
Keystone Const – Eleven Park Mixed-Use Complex – Indiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our Keystone Const – Eleven Park Mixed-Use Complex – Indiana report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of the...
-
Product Insights
Keystone Realtors – Mumbai Rustomjee Paramount Residential Complex – Maharashtra
Equip yourself with the essential tools needed to make informed and profitable decisions with our Keystone Realtors - Mumbai Rustomjee Paramount Residential Complex - Maharashtra report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-001 in Periodontal Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KB-001 in Periodontal Disease Drug Details: KB-001 is under development for the treatment of Alzheimer's...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-001 in Neuroinflammation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KB-001 in Neuroinflammation Drug Details: KB-001 is under development for the treatment of Alzheimer's disease,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-001 in Stroke
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KB-001 in Stroke Drug Details: KB-001 is under development for the treatment of Alzheimer's disease,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ZB-002 in Autoimmune Disorders
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ZB-002 in Autoimmune Disorders Drug Details:ZB-002 (Xtend-TNF) (XmAb-6755) is under development for the treatment of autoimmune...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IONIS-FB-LRx in IgA Nephropathy (Berger’s Disease)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IONIS-FB-LRx in IgA Nephropathy (Berger's Disease) Drug Details:IONIS-FB-LRx is under development for the treatment of geographic...